Kei Higashikawa

Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo

Yuki Shibata, Hironobu Yasui, Kei Higashikawa et al. · PLoS ONE · 2019 · 144 citations · Full text

Medicine, Oncology, Pharmacology +16

64Cu-DOTA-Anti-CTLA-4 mAb Enabled PET Visualization of CTLA-4 on the T-Cell Infiltrating Tumor Tissues

Kei Higashikawa, Katsuharu Yagi, Keiko Watanabe et al. · PLoS ONE · 2014 · 114 citations · Full text

Medicine, Nuclear Medicine, Oncology +14

Carboxyl-, sulfonyl-, and phosphate-terminal dendrimers as a nanoplatform with lymph node targeting

Yutaka Nishimoto, Shu Nagashima, Kohei Nakajima et al. · International Journal of Pharmaceutics · 2020 · 40 citations

Pharmacy, Biochemistry, Pharmaceutics +14

FTY720 Protects Against Ischemia–Reperfusion Injury by Preventing the Redistribution of Tight Junction Proteins and Decreases Inflammation in the Subacute Phase in an Experimental Stroke Model

Zifeng Wang, Kei Higashikawa, Hironobu Yasui et al. · Translational Stroke Research · 2020 · 40 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intolerance

Hideo Nambu, Shingo Takada, Satoshi Maekawa et al. · Cardiovascular Research · 2020 · 38 citations

Life Sciences, Cardiology, Physiology +17